Correlation Between SFRP1 and Colorectal Cancer and Adenoma

NCT05204433 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2022-01-24

No results posted yet for this study

Summary

In summary, our study demonstrated the methylation sites of SFRP1 gene promoter in patients with colorectal cancer and adenoma and found SFRP1\_16\_17\_18 CpG site was good performance as a diagnostic marker of colorectal cancer.

Conditions

  • Early Diagnosis of Colorectal Cancer and Adenoma

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Xijing Hospital of Digestive Diseases

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-05
Primary Completion
2022-02-20
Completion
2022-03-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05204433 on ClinicalTrials.gov